Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04366986 · ClinicalTrials.gov registry record
International Registry of Coronavirus (COVID-19) Exposure in Pregnancy
A clinical trial of COVID-19, sponsored by Pregistry.
- Completed
- Registry status
- 17,318
- Enrollment target
- 1
- Study location
NCT04366986 is a study of COVID-19 that has completed, run by Pregistry. The registered enrollment target is 17,318 participants, below the 55,129-participant average among 203 other COVID-19 trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04366986, a study of COVID-19, has completed, sponsored by Pregistry.
- COMPLETED
- Registry status
- 17,318 participants
- Enrollment target
- 1
- Study location
Study Summary
The International Registry of Coronavirus Exposure in Pregnancy (IRCEP) is a prospective cohort study of pregnant and recently pregnant women who have been tested for SARS-CoV-2 (regardless of the result) or have been clinically diagnosed with COVID-19 by a health care professional. Data from the IRCEP will be used to evaluate the impact of COVID-19 on pregnancy and birth outcomes.
Conditions Studied
Interventions
- OTHER Tested for SARS-CoV-2 (regardless of the result)
- OTHER Clinical diagnosis of COVID-19 by a health care professional
Study Locations (1)
California
- Pregistry - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,318 participants |
| Start Date | 2020-06-23 |
| Est. Completion | 2021-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04366986
The ClinicalTrials.gov registry entry for NCT04366986 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17,318 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,129-participant average among 203 other COVID-19 trials with a reported enrollment target (69% lower). The listed sponsor is Pregistry, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Tested for SARS-CoV-2 (regardless of the result) is the first listed.
NCT04366986 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04366986 about?
NCT04366986 is a clinical study titled "International Registry of Coronavirus (COVID-19) Exposure in Pregnancy". The International Registry of Coronavirus Exposure in Pregnancy (IRCEP) is a prospective cohort study of pregnant and recently pregnant women who have been tested for SARS-CoV-2 (regardless of the result) or have been clinically diagnosed with COVID-19 by a health care professional. Data from the IR...
What is the current status of trial NCT04366986?
This trial is currently completed. The enrollment target is 17,318 participants. The study started on 2020-06-23. Estimated completion is 2021-08-31.
What conditions does trial NCT04366986 study?
This clinical trial studies the following conditions: COVID-19.
What interventions are being tested in trial NCT04366986?
The interventions under investigation include: Tested for SARS-CoV-2 (regardless of the result) (OTHER), Clinical diagnosis of COVID-19 by a health care professional (OTHER).
Who is sponsoring clinical trial NCT04366986?
This trial is sponsored by Pregistry, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04366986 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.